The signaling molecule IL-6, involved in inflammation, is associated with increasing frailty in relapsing-remitting MS, a ...

IL-6 consistently outperformed traditional biomarkers in distinguishing bacterial from non-bacterial infections, with AUROC values of 0.91 in children, 0.94 in maternal patients, and 0.86 in neonates.

Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

The four CARRA consensus treatment plans (CTPs) being compared were glucocorticoids, methotrexate, an IL-1 inhibitor, and an IL-6 inhibitor. Patients kept a home diary on rash, fever, pain ...

The 8 subclinical markers (in 3 domains) assessed were: inflammation (blood levels of high-sensitivity C-reactive protein [hs-CRP] and interleukin-6 [IL-6]); thrombosis (blood levels of fibrinogen and ...

A new randomized trial reveals that anthocyanin supplementation significantly reduces CRP and improves cardiometabolic ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk ...